UBS has increased its price target for Elevance Health (ELV) to $460 from $400, while reconfirming a Buy rating on the stock. This adjustment reflects...
Neutral
This article discusses how healthcare providers are reacting to Elevance Health's out-of-network referral penalties. The author, Caroline Hudson, publ...
Neutral
Major health insurance companies, including UnitedHealthcare, Elevance Health, and Alignment, are actively increasing their financial reserves. This m...
Bullish
Elevance Health (US2855211023) reported better-than-expected first-quarter earnings and raised its full-year guidance for 2026. The insurer's adjusted...
Neutral
The Greater New York Hospital Association (GNYHA) has requested that New York state intervene and block Anthem's new policy. This policy would impose ...
Neutral
Cornerstone Investment Partners LLC trimmed its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 1.3% in the 4th quarter, according to th...
A judge has dismissed Elevance Health's lawsuit challenging Medicare Advantage ratings. This decision prevents the insurer from forcing a review of it...
Bullish
Barclays has increased its price target for Elevance Health (ELV) to $408 from $393, while reiterating an Overweight rating on the stock. This adjustm...
Elevance Health, Inc. published its Q1 2026 earnings call presentation, reporting an EPS of $12.58, beating estimates by $1.77, and revenue of $49.49 ...